These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12465750)

  • 21. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Micronutrients in cancer chemoprevention.
    Greenwald P; Milner JA; Anderson DE; McDonald SS
    Cancer Metastasis Rev; 2002; 21(3-4):217-30. PubMed ID: 12549762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention of prostate cancer.
    Klein EA
    Crit Rev Oncol Hematol; 2005 Apr; 54(1):1-10. PubMed ID: 15780904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of prostate cancer.
    DePrimo SE; Shinghal R; Vidanes G; Brooks JD
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):445-57. PubMed ID: 11525290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SELECT: the selenium and vitamin E cancer prevention trial.
    Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
    Urol Oncol; 2003; 21(1):59-65. PubMed ID: 12684129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer prevention: agent development strategies.
    Parnes HL; House MG; Tangrea JA
    Recent Results Cancer Res; 2014; 202():121-31. PubMed ID: 24531786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of transgenic mice as models for prostate cancer chemoprevention.
    Nguewa PA; Calvo A
    Curr Mol Med; 2010 Nov; 10(8):705-18. PubMed ID: 20937024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on chemoprevention strategies in prostate cancer for 2006.
    Neill MG; Fleshner NE
    Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on chemoprevention of prostate cancer.
    Klein EA; Thompson IM
    Curr Opin Urol; 2004 May; 14(3):143-9. PubMed ID: 15069304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention in prostate cancer.
    Assikis V; Brawley OW
    Curr Probl Cancer; 2004; 28(4):218-30. PubMed ID: 15318324
    [No Abstract]   [Full Text] [Related]  

  • 32. Introductory remarks: development of chemopreventive agents for prostate cancer.
    Kelloff GJ; Boone CW; Malone WF; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16H():1-8. PubMed ID: 1289663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.
    Wang Z; Fan J; Liu M; Yeung S; Chang A; Chow MS; Pon D; Huang Y
    Expert Opin Investig Drugs; 2013 Dec; 22(12):1613-26. PubMed ID: 24050482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of prostate cancer: an updated view.
    Klein EA; Thompson IM
    World J Urol; 2012 Apr; 30(2):189-94. PubMed ID: 22238120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective estrogen receptor modulators for the chemoprevention of prostate cancer.
    Steiner MS; Raghow S; Neubauer BL
    Urology; 2001 Apr; 57(4 Suppl 1):68-72. PubMed ID: 11295598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer chemoprevention: an overview of United States trials.
    Barqawi A; Thompson IM; Crawford ED
    J Urol; 2004 Feb; 171(2 Pt 2):S5-8; discussion S9. PubMed ID: 14713745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents.
    Nelson WG; Wilding G
    Urology; 2001 Apr; 57(4 Suppl 1):56-63. PubMed ID: 11295596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgens and prevention of prostate cancer.
    Sarvis JA; Thompson IM
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.